Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer
Liang Yu, Di Wu, Hugh Gao, Jesse J Balic, Anna Tsykin, Tae-Su Han, You Dong Liu, Catherine L Kennedy, Ji Kun Li, Jie Qi Mao, Patrick Tan, Masanobu Oshima, Gregory J Goodall, Brendan J Jenkins
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2018
Awarded by Association for International Cancer Research (United Kingdom)
Awarded by Cancer Council of Victoria (Australia)
The authors thank Dr. Michael Gantier for advice and comments, and also Meri Najdovska for technical assistance. The authors are grateful to Dr. Daniel Gough for kindly providing the pLVX mCherry construct. This work was supported by grants awarded to B.J. Jenkins from the Association for International Cancer Research (United Kingdom) (Grant Reference Number 11-0017) and Cancer Council of Victoria (Australia) (Grant Reference Number 1003597), as well as the Operational Infrastructure Support Program by the Victorian Government of Australia. B.J. Jenkins is supported by a Senior Research Fellowship awarded by the National Health and Medical Research Council (Australia).